drugset / Trial / NCT01831934
Responses to Influenza Vaccine in Patients With Mitochondrial Disorders (MELAS)
Phase 4
Completed
22 enrolled
Stanford University
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · collab
Non-randomizedParallel-groupOpen-labelBasic science
Summary
This pilot clinical study evaluated the safety and metabolic responses to a licensed inactivated seasonal influenza vaccine (TIV) in mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes syndrome (MELAS) volunteers and controls.
Timeline
- Start
- 2010-09
- Primary completion
- 2011-12
- Completion
- 2012-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Influenza Virus Vaccine | Vaccine | — | Intramuscular |